RADX Competitors & Alternatives

Compare Radiopharm Theranostics Limited American Depositary Shares with similar stocks in the same industry

Biotechnology

RADX

Main Stock
$0.63
-6.33%
Tradestie Score
39
Market Cap
$44.66M
Revenue Growth
-36.9%
Analyst Upside
+2484.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: radiopharmaceutical synthesis, theranostic targeting, isotope labeling
Major Customers 5
nuclear medicine departments oncology clinics hospital systems clinical research organizations pharma partners
Critical Suppliers 3
medical isotope producers contract manufacturing organizations radiochemistry labs
Direct Ecosystem Rivals 3

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
ARTV Artiva Biotherapeutics, Inc. Common Stock
$3.78
-1.31%
$71.32M - 54 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
QTTB Q32 Bio Inc. Common Stock
$8.34
-1.65%
$25.37M 2.4 39 Compare
AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
$0.47
-14.27%
$24.59M - 44 Compare
SPHL Springview Holdings Ltd Class A Ordinary Shares
$2.41
-0.82%
$11.90M - 47 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$9.31
-8.42%
$6.53M - 34 Compare
BAYRY BAYRY
- - - - Compare

Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry